Futura Medical specialises in the development and global commercialisation of innovative consumer-focused sexual health products. Our lead projects are Eroxon®, (available commercially) and Eroxon® Intense and WSD4000 (both in-development). Our core strengths lie in our expertise in research and development, regulatory and business development in the growing sexual health market.
Our lead product is Eroxon®a clinically proven breakthrough treatment for erectile dysfunction
Futura has two new products in its development pipeline, Eroxon® Intense and WSD4000 for the treatment of sexual dysfunction in men and women.
Futura Medical specialises in the development and global commercialisation of innovative and proprietary sexual health products. Our lead product is Eroxon®, a clinically proven breakthrough treatment for erectile dysfunctions.
We are experts in the research, development and commercialisation of topically delivered gel formulation.
WEBCASTS
Videos and webcasts
Shareholder centre
This section contains the latest RNS, news and videos.
Holding(s) in Company
Highly positive data from WSD4000 studies
Correction: Result of AGM
Result of AGM
Read more RNS
Our email news alert service provides a subscription to the RNS news from Futura Medical.
Sign up to our Alert Service
15 April 2025
04 November 2024
©2026 Futura Medical